Finally, a recent work described a novel small-molecule modulator of GCase (S-181) able to increase wild-type GCase activity in iPSC-derived DA neurons from patients with 84GG-GBA, as well as in LRRK2, Parkin, DJ1-linked, or sporadic PD patients [62]. The gene discussed is LRRK2; the disease is Parkinson disease.